Oxford BioTherapeutics is a biotechnology company focused on developing antibody-drug conjugates and other innovative therapeutics for the treatment of various diseases, particularly cancer. They leverage their proprietary technologies and drug discovery platforms to identify and create targeted therapies that aim to improve patient outcomes.